Aurobindo Pharma Limited (AUROPHARMA.NS)
INR 1266.0
(1.48%)
INR 1266.0
(1.48%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 104.5 Billion INR | 69.37% |
| 2022 | 25.51 Billion INR | -22.83% |
| 2021 | 33.06 Billion INR | -25.76% |
| 2020 | 44.53 Billion INR | 13.03% |
| 2019 | 39.4 Billion INR | 19.09% |
| 2018 | 33.08 Billion INR | 1.26% |
| 2017 | 32.67 Billion INR | 7.41% |
| 2016 | 30.42 Billion INR | 6.21% |
| 2015 | 28.64 Billion INR | 23.13% |
| 2014 | 23.26 Billion INR | 23.99% |
| 2013 | 18.76 Billion INR | 170.32% |
| 2012 | 6.94 Billion INR | 60.9% |
| 2011 | 4.31 Billion INR | -49.9% |
| 2010 | 8.6 Billion INR | 4.99% |
| 2009 | 8.2 Billion INR | 370.89% |
| 2008 | 1.74 Billion INR | -48.07% |
| 2007 | 3.35 Billion INR | 33.4% |
| 2006 | 2.51 Billion INR | 82.08% |
| 2005 | 1.38 Billion INR | 102.35% |
| 2004 | 682.3 Million INR | -65.48% |
| 2003 | 1.97 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 12.15 Billion INR | 156.79% |
| 2023 Q2 | 11.43 Billion INR | 38.68% |
| 2023 Q3 | 13.37 Billion INR | 16.97% |
| 2023 Q4 | 13.32 Billion INR | -0.39% |
| 2023 FY | 43.21 Billion INR | 69.37% |
| 2023 Q1 | 8.24 Billion INR | 4.98% |
| 2022 FY | 25.51 Billion INR | -22.83% |
| 2022 Q2 | 5.48 Billion INR | -19.93% |
| 2022 Q1 | 6.85 Billion INR | -4.94% |
| 2022 Q3 | 7.25 Billion INR | 32.16% |
| 2022 Q4 | 7.85 Billion INR | 8.36% |
| 2021 Q2 | 8.92 Billion INR | -4.0% |
| 2021 Q3 | 7.17 Billion INR | -19.64% |
| 2021 Q4 | 7.2 Billion INR | 0.5% |
| 2021 Q1 | 9.29 Billion INR | -22.98% |
| 2021 FY | 33.06 Billion INR | -25.76% |
| 2020 Q2 | 11.75 Billion INR | 17.33% |
| 2020 Q3 | 10.92 Billion INR | -7.1% |
| 2020 FY | 44.53 Billion INR | 13.03% |
| 2020 Q4 | 12.07 Billion INR | 10.53% |
| 2020 Q1 | 10.01 Billion INR | -13.19% |
| 2019 Q1 | 9.05 Billion INR | 0.82% |
| 2019 FY | 39.4 Billion INR | 19.09% |
| 2019 Q4 | 11.53 Billion INR | 20.47% |
| 2019 Q3 | 9.57 Billion INR | 3.65% |
| 2019 Q2 | 9.24 Billion INR | 2.05% |
| 2018 Q1 | 6.24 Billion INR | -3.51% |
| 2018 FY | 33.08 Billion INR | 1.26% |
| 2018 Q4 | 8.98 Billion INR | -2.72% |
| 2018 Q3 | 9.23 Billion INR | 7.07% |
| 2018 Q2 | 8.62 Billion INR | 38.04% |
| 2017 Q1 | 7.1 Billion INR | 14.36% |
| 2017 FY | 32.67 Billion INR | 7.41% |
| 2017 Q4 | 6.47 Billion INR | -27.05% |
| 2017 Q3 | 8.87 Billion INR | -9.92% |
| 2017 Q2 | 9.85 Billion INR | 38.68% |
| 2016 Q3 | 7.83 Billion INR | -4.31% |
| 2016 FY | 30.42 Billion INR | 6.21% |
| 2016 Q2 | 8.19 Billion INR | 4.64% |
| 2016 Q1 | 7.82 Billion INR | 3.69% |
| 2016 Q4 | 6.21 Billion INR | -20.74% |
| 2015 Q2 | 6.82 Billion INR | 7.44% |
| 2015 Q4 | 7.54 Billion INR | 4.33% |
| 2015 Q3 | 7.23 Billion INR | 5.96% |
| 2015 Q1 | 6.35 Billion INR | -4.66% |
| 2015 FY | 28.64 Billion INR | 23.13% |
| 2014 Q1 | 5.67 Billion INR | -20.18% |
| 2014 FY | 23.26 Billion INR | 23.99% |
| 2014 Q4 | 6.66 Billion INR | 22.33% |
| 2014 Q3 | 5.44 Billion INR | -0.45% |
| 2014 Q2 | 5.47 Billion INR | -3.52% |
| 2013 FY | 18.76 Billion INR | 170.32% |
| 2013 Q4 | 7.1 Billion INR | 25.17% |
| 2013 Q1 | 2.35 Billion INR | 5.09% |
| 2013 Q2 | 3.61 Billion INR | 53.41% |
| 2013 Q3 | 5.67 Billion INR | 56.98% |
| 2012 FY | 6.94 Billion INR | 60.9% |
| 2012 Q4 | 2.24 Billion INR | 13.14% |
| 2012 Q3 | 1.98 Billion INR | 4.13% |
| 2012 Q1 | 809.1 Million INR | -25.23% |
| 2012 Q2 | 1.9 Billion INR | 135.38% |
| 2011 Q3 | 1.35 Billion INR | 0.0% |
| 2011 Q4 | 1.08 Billion INR | -20.4% |
| 2011 FY | 4.31 Billion INR | -49.9% |
| 2010 FY | 8.6 Billion INR | 4.99% |
| 2009 FY | 8.2 Billion INR | 370.89% |
| 2008 FY | 1.74 Billion INR | -48.07% |
| 2007 FY | 3.35 Billion INR | 33.4% |
| 2006 FY | 2.51 Billion INR | 82.08% |
| 2005 FY | 1.38 Billion INR | 102.35% |
| 2004 FY | 682.3 Million INR | -65.48% |
| 2003 FY | 1.97 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -6990.317% |
| Ind-Swift Limited | 1.22 Billion INR | -8424.223% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -20990.34% |
| Innova Captab Limited | 2.53 Billion INR | -4025.029% |
| Divi's Laboratories Limited | 18.31 Billion INR | -470.748% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -2235.857% |
| Morepen Laboratories Limited | 4.17 Billion INR | -2403.788% |
| Mankind Pharma Limited | 40.86 Billion INR | -155.713% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -6021.337% |
| Laurus Labs Limited | 3.94 Billion INR | -2546.606% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -2586.068% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -1063.846% |
| Alembic Limited | 767.77 Million INR | -13511.355% |
| Hikal Limited | 1.49 Billion INR | -6893.97% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -1714.902% |
| Neuland Laboratories Limited | 5.31 Billion INR | -1865.064% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -1285.692% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -1507.164% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -2014.522% |
| Themis Medicare Limited | 1.3 Billion INR | -7919.607% |
| RPG Life Sciences Limited | 2.29 Billion INR | -4458.91% |
| Zydus Lifesciences Limited | 45.39 Billion INR | -130.225% |
| Lupin Limited | 27.75 Billion INR | -276.481% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -16727.594% |
| Wockhardt Limited | 140 Million INR | -74545.643% |
| Vaishali Pharma Limited | 6.29 Million INR | -1660273.371% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -3240.794% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -48724.472% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -1913.951% |
| FDC Limited | 3.03 Billion INR | -3344.722% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | -54.297% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -50130.185% |
| Eris Lifesciences Limited | 5.18 Billion INR | -1916.78% |
| Venus Remedies Limited | 534.65 Million INR | -19446.19% |
| ZIM Laboratories Limited | 1.09 Billion INR | -9416.68% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -8389.343% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -18845.973% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -1346.361% |
| Shilpa Medicare Limited | 3.76 Billion INR | -2678.198% |
| Albert David Limited | 1.33 Billion INR | -7731.193% |
| Ajanta Pharma Limited | 19.67 Billion INR | -431.089% |
| Hester Biosciences Limited | 364.77 Million INR | -28549.258% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -2168.055% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 2812.344% |
| Gufic Biosciences Limited | 2.89 Billion INR | -3511.298% |
| Windlas Biotech Limited | 1.29 Billion INR | -7945.631% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -3651.037% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -3691539.825% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -380495.455% |
| Granules India Limited | 6.52 Billion INR | -1500.793% |
| Aarti Drugs Limited | 7.14 Billion INR | -1361.854% |
| Bal Pharma Limited | 214.56 Million INR | -48604.1% |
| Alkem Laboratories Limited | 19.46 Billion INR | -436.967% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | -0.192% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -5381.947% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -43871.834% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -505825.155% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -4326.11% |
| Medico Remedies Limited | 277.11 Million INR | -37610.975% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -5101.702% |
| Ipca Laboratories Limited | 29.59 Billion INR | -253.095% |
| Brooks Laboratories Limited | -72.25 Million INR | 144738.072% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -41827.174% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -312.485% |
| NATCO Pharma Limited | 25.96 Billion INR | -302.526% |
| Suven Life Sciences Limited | -1.22 Billion INR | 8625.21% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -1899.765% |
| Indoco Remedies Limited | 1.52 Billion INR | -6755.412% |
| Alpa Laboratories Limited | 61.51 Million INR | -169783.606% |
| Lasa Supergenerics Limited | -458 Million INR | 22917.196% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 2639.559% |